TITLE

Renal Risks Lower with Metformin Use

PUB. DATE
February 2012
SOURCE
Renal & Urology News;Feb2012, Vol. 11 Issue 2, p22
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the health effects of the use of metformin as first-time treatment for patients with type 2 diabetes.
ACCESSION #
73344766

 

Related Articles

  • Acarbose noninferior to metformin in type 2 diabetes.  // Endocrine Today;Nov2013, Vol. 11 Issue 11, p9 

    The article discusses a research study published in an issue of the journal "The Lancet" which found that patients with type 2 diabetes treated with acarbose experienced similar improvements in HbAlc as those treated with metformin.

  • Diabetes drugs not always best option. Wilson, Clare // New Scientist;7/5/2014, Vol. 223 Issue 2976, p12 

    The article discusses a 2014 report in the "JAMA Internal Medicine" on a study by Sandeep Vijan at the University of Michigan, Ann Arbor, and colleagues that suggests the drug metformin for the treatment of type 2 diabetes could be counterproductive for people with slightly raised blood sugar.

  • Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Kaixin Zhou; Bellenguez, Celine; Spencer, Chris C. A.; Bennett, Amanda J.; Coleman, Ruth L.; Tavendale, Roger; Hawley, Simon A.; Donnelly, Louise A.; Schofield, Chris; Groves, Christopher J.; Burch, Lindsay; Carr, Fiona; Strange, Amy; Freeman, Colin; Blackwell, Jenefer M; Bramon, Elvira; Brown, Mattew; Casas, Juan P.; Corvin, Aiden; Craddock, Nicholas // Nature Genetics;Feb2011, Vol. 43 Issue 2, p117 

    Metformin is the most commonly used pharmacological therapy for type 2 diabetes. We report a genome-wide association study for glycemic response to metformin in 1,024 Scottish individuals with type 2 diabetes with replication in two cohorts including 1,783 Scottish individuals and 1,113...

  • The antidiabetic gutsy role of metformin uncovered? Burcelin, Rémy // Gut;May2014, Vol. 63 Issue 5, p706 

    The author comments on the research study concerning on the medical role of metformin as treatment for lowering hyperglycaemia in type 2 diabetic patients. He mentions the antidiabetic effect of metformin abrogated by an antibiotic treatment reinforcing the significant of gut microbiota. He also...

  • Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. BRIDGES, Hannah R.; JONES, Andrew J. Y.; POLLAK, Michael N.; HIRST, Judy // Biochemical Journal;9/15/2014, Vol. 462 Issue 3, p475 

    The biguanide metformin is widely prescribed for Type II diabetes and has anti-neoplastic activity in laboratory models. Despite evidence that inhibition of mitochondrial respiratory complex I by metformin is the primary cause of its cell-lineage-specific actions and therapeutic effects, the...

  • Metformin still underutilised in the USA.  // PharmacoEconomics & Outcomes News;3/17/2012, Issue 649, p4 

    The article reports on a study which examined the utilization of metformin in the treatment of type 2 diabetes in the U.S.

  • Metformin.  // Reactions Weekly;2/23/2013, Issue 1440, p25 

    The article presents a case study of a 71-year-old man who developed pseudoporphyria after receiving treatment with metformin for type 2 diabetes mellitus.

  • Metformin in the Treatment of Obese Children and Adolescents at Risk of Type 2 Diabetes. Kendall, Deborah; Amin, Rakesh; Clayton, Peter // Pediatric Drugs;Feb2014, Vol. 16 Issue 1, p13 

    Metformin is the first-line treatment for type 2 diabetes (T2D) in adults, children and young people, particularly in obese or overweight patients. Many studies have demonstrated that metformin is associated with weight reduction in adults and in prevention or delay of T2D onset in those who are...

  • Treating Patients with "DIABESITY": Challenges and Opportunities. Still, Christopher // Bariatric Times;May2015, Vol. 12 Issue 5, p3 

    The author discusses the newer medications that treat type 2 diabetes mellitus (T2DM) while helping patients with weight loss and maintenance. He cites Metformin as an insulin sensitizer that works on the liver to help the body be more sensitive or use insulin more efficiently so the body does...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics